COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually
In an interview with the JAMA on June 2, 2020, Anthony Fauci, MD, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said that while he was “cautiously optimistic” about the effectiveness of the vaccines being developed for COVID-19, he was concerned that any protection the vaccines may provide might only be temporary. […]
Pfizer/BioNTech Target Fall 2020 for COVID-19 Vaccine Availability
In recent weeks Inovio Pharmaceuticals of Pennsylvania and representatives of the German biotechnology firm CureVac AG and the University of Oxford in the United Kingdom have announced that their experimental COVID-19 vaccines will be ready for use by September 2020. On Apr. 29, 2020, Pfizer, Inc. of New York stated in a news release that […]
Inovio COVID-19 Vaccine Uses Electricity to Drive DNA Into Body Cells
Story Highlights Inovio Pharmaceuticals has started Phase 1 testing of its experimental COVID-19 DNA vaccine in healthy volunteers. The U.S. biotech firm has already produced enough of the vaccine to support Phase 1 (immune system reactivity and safety) and Phase 2 (efficacy) testing and plans to have one million doses ready for distribution by the […]
COVID-19 Meltdown and Pharma’s Big Money Win
Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases (NIAID) told Americans on Apr. 1, 2020 that modeling reports suggested COVID-19 infections could eventually “kill 100,000 to 240,000 Americans,”1 2 3 which was considerably less than the worst case 1.7 million mortality figure the Centers for Disease Control and Prevention (CDC) […]
University of Pittsburgh Researchers Use Genetically Modified Measles Vaccine to Create COVID-19 Vaccine
Vaccine developers at the University of Pittsburgh’s Center for Vaccine Research (CVR) have taken a part of the coronavirus involved in COVID-19 infection and attached it to a genetically modified measles vaccine that has been used for many years.1 According to CVR Director Dr. Paul Duprex, “CVR has a mandated role to respond rapidly to […]
Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine
Story Highlights In light of the coronavirus outbreak, three research teams have been awarded grants by the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the novel coronavirus. In a public-private partnership with NIH, Moderna, Inc. is using an experimental mRNA technology to develop a vaccine. Johnson & Johnson and other drug companies […]
